HomeSLRX • NASDAQ
add
Salarius Pharmaceuticals Inc
Previous close
$1.63
Day range
$1.55 - $1.63
Year range
$1.22 - $7.20
Market cap
2.26M USD
Avg Volume
74.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.01M | -60.25% |
Net income | -972.12K | 60.20% |
Net profit margin | — | — |
Earnings per share | -0.76 | 85.38% |
EBITDA | -1.01M | 60.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.28M | -56.68% |
Total assets | 3.86M | -54.08% |
Total liabilities | 934.58K | -59.73% |
Total equity | 2.92M | — |
Shares outstanding | 1.44M | — |
Price to book | 0.80 | — |
Return on assets | -67.89% | — |
Return on capital | -89.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -972.12K | 60.20% |
Cash from operations | -1.36M | 63.81% |
Cash from investing | — | — |
Cash from financing | 1.37M | 745.75% |
Net change in cash | 11.21K | 100.28% |
Free cash flow | -1.50M | 59.35% |
About
Founded
2014
Headquarters
Website
Employees
2
